These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4922228)

  • 41. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome.
    Fehling C
    Acta Neurol Scand; 1973; 49(2):245-51. PubMed ID: 4577929
    [No Abstract]   [Full Text] [Related]  

  • 42. [Amantadine in the treatment of Parkinson's disease. Results of one year].
    Dalle Ore G; Bricolo A; Buffatti P; Bazzan A; Mazza C
    Minerva Med; 1971 Oct; 62(82):3943-7. PubMed ID: 5125047
    [No Abstract]   [Full Text] [Related]  

  • 43. ["Nil nocere." Side effects during treatment of Parkinson's disease with amantadine].
    Diehl LW
    Munch Med Wochenschr; 1972 Mar; 114(10):445-7. PubMed ID: 4625982
    [No Abstract]   [Full Text] [Related]  

  • 44. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879
    [No Abstract]   [Full Text] [Related]  

  • 46. Amantadine for Parkinson's disease.
    Fieschi C; Nardini M; Casacchia M; Tedone ME
    Lancet; 1970 May; 1(7653):945-6. PubMed ID: 4191565
    [No Abstract]   [Full Text] [Related]  

  • 47. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.
    Callagham N; Mcllroy M; O'Connor M
    Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744
    [No Abstract]   [Full Text] [Related]  

  • 49. Amantadine for Parkinson's disease.
    Mann DC; Pearce LA; Waterbury LD
    Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study].
    Schneider E; Fischer PA; Clemens R; Balzereit F; Fünfgeld EW; Haase HJ
    Dtsch Med Wochenschr; 1984 Jun; 109(25):987-90. PubMed ID: 6734455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 52. A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease.
    Walker JE; Albers JW; Tourtellotte WW; Henderson WG; Potvin AR; Smith A
    J Chronic Dis; 1972 Mar; 25(3):149-82. PubMed ID: 4555278
    [No Abstract]   [Full Text] [Related]  

  • 53. [Amantadine in Parkinson's disease].
    Vecchi L
    Clin Ter; 1971 Jun; 57(5):471-5. PubMed ID: 5113576
    [No Abstract]   [Full Text] [Related]  

  • 54. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of amantadine in Parkinson's disease. Results of a double-blind trial.
    Dallos V; Heathfield K; Stone P; Allen FA
    Br Med J; 1970 Oct; 4(5726):24-6. PubMed ID: 4919119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 57. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J; Raymondeaud C
    Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract]   [Full Text] [Related]  

  • 58. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM
    Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G
    Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.